Clinical trials referral resource. Current clinical trials of erlotinib.
Dancey
Janet E
JE
National Cancer Institute, Bethesda, MD, USA.
Schoenfeldt
Mason
M
D000970:Antineoplastic Agents / Q000627:therapeutic use; D014408:Biomarkers, Tumor / Q000378:metabolism; D002986:Clinical Trials as Topic; D066246:ErbB Receptors / Q000187:drug effects / Q000378:metabolism; D000069347:Erlotinib Hydrochloride; D006801:Humans; D047428:Protein Kinase Inhibitors / Q000627:therapeutic use; D011799:Quinazolines / Q000627:therapeutic use
D000970:Antineoplastic Agents; D014408:Biomarkers, Tumor; D047428:Protein Kinase Inhibitors; D011799:Quinazolines; D000069347:Erlotinib Hydrochloride; D066246:ErbB Receptors